Literature DB >> 29949521

Respiratory-resolved MR-based attenuation correction for motion-compensated cardiac PET-MR.

Christoph Kolbitsch1, Radhouene Neji, Matthias Fenchel, Andrew Mallia, Paul Marsden, Tobias Schaeffter.   

Abstract

Respiratory motion during cardiac PET acquisitions can cause image blurring and erroneous uptake quantification. In particular the misalignment of attenuation correction (AC) maps and PET emission data can lead to severe quantification errors, because the AC value of the heart is five times higher than of the surrounding lung tissue. Standard PET-MR approaches assume accurate alignment between breathhold MR-based AC maps and free-breathing PET emission data but cannot necessarily ensure it. Here we propose a 75 s free-breathing MR-acquisition, which provides respiratory-resolved AC maps (ACDyn) and non-rigid respiratory motion information. This approach ensures accurate AC for free-breathing PET data and the motion information can be utilized to reduce image blurring caused by respiratory motion. 3D multi-echo MR data was acquired during a 75 s free-breathing scan in six patients. Both a respiratory-resolved dynamic AC map (ACDyn) and a non-rigid respiratory motion field are provided by the MR scan. ACDyn yielded AC values for different breathing phases ensuring accurate AC for each respiratory phase of the free-breathing PET data. In addition, motion-corrected image reconstruction (MCIR) of MR and PET data was used to minimize breathing artefacts. Motion amplitudes in the left ventricle were 8.2  ±  2.9 mm with a dominant motion direction along the anterior-anterolateral and inferior-inferoseptal axis of the heart. The proposed ACDyn-MCIR technique led to significant signal recovery of PET tracer uptake by 24  ±  5% (p  <  0.05). The maximum improvement was observed in patients with large misalignment between standard breathhold MR-based AC maps and PET emission data. PET image resolution was improved by 20  ±  12% (p  <  0.05). We have presented an efficient MR-scan, which ensures accurate motion information and AC values to improve PET quantification for cardiac PET-MR scans. The short scan time of 75 s makes this free-breathing acquisition easy to integrate into standard clinical PET-MR protocols.

Entities:  

Mesh:

Year:  2018        PMID: 29949521     DOI: 10.1088/1361-6560/aaca15

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  5 in total

Review 1.  The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.

Authors:  Tom Konert; Jeroen B van de Kamer; Jan-Jakob Sonke; Wouter V Vogel
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

2.  Evaluation of synergistic image registration for motion-corrected coronary NaF-PET-MR.

Authors:  Johannes Mayer; Yining Jin; Thomas-Heinrich Wurster; Marcus R Makowski; Christoph Kolbitsch
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2021-05-10       Impact factor: 4.226

3.  MR-guided motion-corrected PET image reconstruction for cardiac PET-MR.

Authors:  Camila Munoz; Sam Ellis; Stephan G Nekolla; Karl P Kunze; Teresa Vitadello; Radhouene Neji; Rene M Botnar; Julia A Schnabel; Andrew J Reader; Claudia Prieto
Journal:  J Nucl Med       Date:  2021-05-28       Impact factor: 11.082

4.  Assessing the qualitative and quantitative impacts of simple two-class vs multiple tissue-class MR-based attenuation correction for cardiac PET/MR.

Authors:  Philip M Robson; Vittoria Vergani; Thomas Benkert; Maria Giovanna Trivieri; Nicolas A Karakatsanis; Ronan Abgral; Marc R Dweck; Pedro R Moreno; Jason C Kovacic; Kai Tobias Block; Zahi A Fayad
Journal:  J Nucl Cardiol       Date:  2020-01-02       Impact factor: 3.872

Review 5.  PET/MRI attenuation estimation in the lung: A review of past, present, and potential techniques.

Authors:  Joseph Lillington; Ludovica Brusaferri; Kerstin Kläser; Karin Shmueli; Radhouene Neji; Brian F Hutton; Francesco Fraioli; Simon Arridge; Manuel Jorge Cardoso; Sebastien Ourselin; Kris Thielemans; David Atkinson
Journal:  Med Phys       Date:  2020-01-01       Impact factor: 4.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.